CLASTEON
Identification of Clasteon
| No description |
Google image searchProduct monograph
Active ingredient
clodronate disodium, 400 MG
DIN: 02245828
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUMITOMO PHARMA CANADA, INC.
Date: 18-OCT-2023
ATC:
- M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
- M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
- M05BA — Bisphosphonates (ATC, ATC/DDD)
- M05BA02 — CLODRONIC ACID (ATC/DDD)
Reference brand drug: Bonefos, Clasteon
Pharmaceutical standard: MFR
